Comprehensive Clinical Evaluation Study of GLP-1RA
Launched by LI YAN · Nov 12, 2024
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding the best glucagon-like peptide-1 receptor agonists (often called GLP-1RAs) for treating adults with type 2 diabetes. The goal is to understand how these medications work in real-life situations, looking at important factors like safety, effectiveness, cost, and how easily patients can access them. By doing this, researchers hope to ensure that these drugs are used safely and effectively to help manage diabetes.
To participate in the study, individuals need to be at least 18 years old and have been diagnosed with type 2 diabetes. They should not have used any study drugs in the last three months and must be able to provide complete medical information. Some people may not be eligible if they have certain health conditions, such as severe liver or kidney issues, or if they are pregnant or breastfeeding. Participants will be closely monitored throughout the trial, allowing researchers to gather valuable data that could improve diabetes treatment for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with type 2 diabetes;
- • no study drug has been used in the last three months;
- • Existing hypoglycemic programs include investigational drugs;
- • Age ≥18 years old;
- • The patient's demographic data, disease history, course records, laboratory test indicators, drug use and other information were complete;
- • Sign informed consent.
- Exclusion Criteria:
- • persistent influenza, autoimmune disease, or other metabolic disease;
- • There are obvious gastrointestinal diseases, gastrointestinal resection or malabsorption syndrome;
- • diet drugs, glucocorticoids, drugs affecting gastrointestinal motility are being used;
- • Patients with severe liver and kidney function impairment and patients with malignant tumors;
- • Pregnant or lactating women.
About Li Yan
Li Yan is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and adherence to regulatory standards, Li Yan collaborates with a network of healthcare professionals and research institutions to design and implement clinical trials that address critical health challenges. The organization prioritizes patient safety and ethical considerations, ensuring that all trials contribute valuable data to the medical community while fostering transparency and collaboration throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan, China
Patients applied
Trial Officials
Yining Dong, pharmacist
Principal Investigator
Shandong Third Hospital
Zhongming Wu, doctor
Principal Investigator
Endocrine and Metabolic Disease Hospital of Shandong First Medical University
Yue Liu, pharmacist
Principal Investigator
Shandong University of Traditional Chinese Medicine
Dandan Wu, pharmacist
Principal Investigator
Affiliated Hospital of Binzhou Medical College
Jing Peng, pharmacist
Principal Investigator
Jining Medical University
Qi Wang, pharmacist
Principal Investigator
Jinan Fifth People's Hospital
Zhaohui Meng, pharmacist
Principal Investigator
Jinan Laiwu People's Hospital
Dong wei Wang, doctor
Principal Investigator
Jinan Mental Health Center
Zhong Yuan, pharmacist
Principal Investigator
Jinan Municipal Hospital
Ming Xue, pharmacist
Principal Investigator
Jinan Hospital, Guang'anmen Hospital, China Academy of Traditional Chinese Medicine, China
Jing Lin, pharmacist
Principal Investigator
Shijhong District People's Hospital
Xingshan Wang, doctor
Principal Investigator
Changqing District Hospital of Traditional Chinese Medicine
Min Fan, pharmacist
Principal Investigator
Pingyin County People's Hospital
Xue Zheng, pharmacist
Principal Investigator
Zibo Center Hospital
Ming Xu, pharmacist
Principal Investigator
Zibo First Hospital
Yan Song, pharmacist
Principal Investigator
Zibo Municipal Hospital
Ruoxun Liu, pharmacist
Principal Investigator
Zibo Hospital of Traditional Chinese Medicine
Qing Zhao, doctor
Principal Investigator
Linzi District Maternal and Child Health Center
Zhenwei Chen, pharmacist
Principal Investigator
Yiyuan County People's Hospital
Zhiyan Li, pharmacist
Principal Investigator
Zaozhuang Municipal Hospital
Shenling Cheng, pharmacist
Principal Investigator
Tengzhou Central People's Hospital
Qixia Zhao, pharmacist
Principal Investigator
Zaozhuang Shanting District People's Hospital
Jintang Ning, pharmacist
Principal Investigator
Dongying People's Hospital
Juying Ding, pharmacist
Principal Investigator
Shengli Oilfield Hospital
Jiaxi Jiang, pharmacist
Principal Investigator
Haiyang People's Hospital
Guichun Wang, pharmacist
Principal Investigator
Longko People's Hospital
Zhentian Cheng, pharmacist
Principal Investigator
Weifang Yidu Center Hospital
Yueliang Ji, doctor
Principal Investigator
Fangzi District People's Hospital
Donglou Liang, pharmacist
Principal Investigator
Jining First People's Hospital
Li Zhang, pharmacist
Principal Investigator
QuFu People's Hospital
Guifeng Tan, doctor
Principal Investigator
Wenshang County People's Hospital
Ronghua Wang, pharmacist
Principal Investigator
Weihai Maternal and Child Health Center
Jianfang Liu, pharmacist
Principal Investigator
Rizhao People's Hospital
Xiangju Tian, doctor
Principal Investigator
Linyi Hospital of Traditional Chinese Medicine
Pengcheng Du, pharmacist
Principal Investigator
Shandong University Qilu Hospital, Dezhou Hospital
Fujian Xu, pharmacist
Principal Investigator
Heze Municipal Hospital
Deping Ho, pharmacist
Principal Investigator
Heze Third People's Hospital
Jingyong Xue, pharmacist
Principal Investigator
Heze Mudan People's Hospital
Lishun Yin, pharmacist
Principal Investigator
Heze Dingtao District People's Hospital
Shengmei Wei, pharmacist
Principal Investigator
Caoxian People's Hospital
Jing Meng, pharmacist
Principal Investigator
Shanxian Central Hospital
Ye Fan, pharmacist
Principal Investigator
Yuncheng County People's Hospital
Jingjing Zhang, pharmacist
Principal Investigator
Qingdao Eighth People's Hospital
Wenqian Han, pharmacist
Principal Investigator
Tai'an Central Hospital
Wenwen Lv, pharmacist
Principal Investigator
Affiliated Hospital of Binzhou Medical College
Tao Geng, pharmacist
Principal Investigator
The Second Affiliated Hospital of Shandong First Medical University
Fang Liu, pharmacist
Principal Investigator
Shengli Oilfield Hospital
Congrong Wang, pharmacist
Principal Investigator
Shandong Public Health Clinical Center
Ping Wang, pharmacist
Principal Investigator
Tengzhou Central People's Hospital
Yuxia Gao, pharmacist
Principal Investigator
Dongying Hospital Affiliated to Shandong University of Traditional Chinese Medicine (Dongying Hospital of Traditional Chinese Medicine)
Bo Liu, pharmacist
Principal Investigator
Qingdao Central Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported